Publications by authors named "Maria Piribauer"

Claim this Profile
I
IgD-λ myeloma with extensive free light-chain excretion: a diagnostic pitfall in the identification of monoclonal gammopathies.
Christoph Robier, Maria Piribauer, Christine Beham-Schmid, Kristina Aubell, Manfred Neubauer

Clin Chem Lab Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience.
Martina Baur, Matthias Preusser, Maria Piribauer, Katarzyna Elandt, Marco Hassler

Radiol Oncol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients.
Ola Dale, Maria Piribauer, Stein Kaasa, Kristin Moksnes, Heidi Knobel

J Pain Symptom Manage· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience.
Alexandra Böhm, Maria Piribauer, Friedrich Wimazal, Klaus Geissler, Heinz Gisslinger

Leuk Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy.
Stefan Oberndorfer, Maria Piribauer, Christine Marosi, Heinz Lahrmann, Peter Hitzenberger

J Neurooncol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary study on pharmacokinetics of dacarbazine and fotemustine in glioblastoma multiforme patients does not indicate gender-specific differences.
Barbara Fazeny-Dörner, Robert M Mader, Maria Piribauer, Blanka Rizovski, Barbara Stögermaier

Anticancer Drugs· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5).
Wolfgang R Sperr, Maria Piribauer, Friedrich Wimazal, Christa Fonatsch, Renate Thalhammer-Scherrer

Clin Cancer Res· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stabilization of a progressive hemangioblastoma under treatment with thalidomide.
Maria Piribauer, Thomas Czech, Karin Dieckmann, Peter Birner, Johannes A Hainfellner

J Neurooncol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic and comparative genomic hybridization findings in four cases of breast cancer after neoadjuvant chemotherapy.
Barbara Fazeny-Dörner, Maria Piribauer, Catharina Wenzel, Negar Fakhrai, Christine Pirker

Cancer Genet Cytogenet· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme.
Barbara Fazeny-Dörner, Mario Veitl, Catharina Wenzel, Maria Piribauer, Karl Rössler

Anticancer Drugs· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center.
Barbara Fazeny-Dörner, Anwar Gyries, Karl Rössler, Karl Ungersböck, Thomas Czech, Maria Piribauer

Wien Klin Wochenschr· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival and prognostic factors of patients with unresectable glioblastoma multiforme.
Barbara Fazeny-Dörner, Catharina Wenzel, Mario Veitl, Maria Piribauer, Karl Rössler

Anticancer Drugs· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes.
Peter Birner, Maria Piribauer, Ingeborg Fischer, Brigitte Gatterbauer, Christine Marosi

Brain Pathol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and toxicity of CCNU therapy in elderly patients with glioblastoma multiforme.
Maria Piribauer, Barbara Fazeny-Dörner, Karl Rössler, Karl Ungersböck, Thomas Czech

Anticancer Drugs· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic relevance of p53 protein expression in glioblastoma.
Peter Birner, Maria Piribauer, Ingeborg Fischer, Brigitte Gatterbauer, Christine Marosi

Oncol Rep· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients.
Markus Bredel, Maria Piribauer, Christine Marosi, Peter Birner, Brigitte Gatterbauer

Eur J Cancer· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis